Impact of COVID-19 Pandemic on Breast Biopsy Market Share, Growth By Top Company, Region, Applications, Drivers, Trends & Forecast to 2027

Breast Biopsy Market – Overview

The breast cancer market is expected to witness tremendous growth owing to the rising prevalence of breast cancer. Other key factors such as the growing obesity among women, menstrual history, change in sedentary lifestyle, not having children, socioeconomic factors, and growing consumption of unhealthy diet are contributing towards the growth of the market. Research suggests that other factors such as smoking, exposure to chemicals that can lead to cancer, and working in night shift also may increase the risk of breast cancer. However, factors such as high cost of diagnostic procedures, expensive treatments, and side effects associated with breast biopsy procedures are expected to restrict the market growth during the forecast period.

Free Sample Copy of  With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/6288 

The prevalence of breast cancer has led to an increased level of reliance on breast biopsy procedures. Improved screening campaigns are also increasing the need for breast biopsy procedures. Furthermore, the rise in the awareness regarding cancer is anticipated to further motivate the expansion of the breast biopsy market in the forecast period.

Competitive Analysis:

Leading players in the global Biopsy Breast Market Procedure include Sonocine Inc., Toshiba Corporation, Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Fujifilm Holdings Corporation, Hologic Inc., Koninklijke Philips N.V., Siemens, and GE. 

In September 2019, Candelis Inc. launched a new Advanced Breast Imaging Workstation as an enhancement to its ImageGrid platform.

Segmentation:

The global breast imaging market is segmented on the basis of type, application, end user, and region.

On the basis of type, the breast imaging market is segmented into mammography, CT, PET, MRI, ultrasound, breast biopsy, tactile imaging, and others. Mammography is further segmented into film-screen mammography, full-field digital mammography (FFDM), 3D mammography, scintimammography or molecular breast imaging, and others. Breast biopsy is further segmented into image-guided breast biopsy, tactic core biopsy, ultrasound-guided core biopsy, and others.

On the basis of application, the global breast imaging market is segmented into breast cancer diagnosis, post-neoadjuvant chemotherapy, metastatic axillary adenocarcinoma, and others.

On the basis of end user, the market is segmented into hospitals, diagnostic centers, and others.

Regional Analysis:

The Americas is the largest regional market for breast imaging. The widespread awareness about breast cancer in the region has been a primary driver for the breast imaging market, as it has driven consistent product development in the breast imaging market. Women in the country don’t view breast cancer as a taboo and are proactive in fighting the disease on their own terms. This has driven significant growth of the breast imaging market. The growing prevalence of breast cancer in the region is also likely to remain a major driver for the breast imaging market in the Americas. 

Europe holds the second largest share in the global breast imaging market, followed by Asia Pacific. China, Japan, and India are likely to emerge as important markets in the coming years, enabling steady growth of the breast imaging market in Asia Pacific.

Key players

Some of the key players in the global breast biopsy market are Leica Biosystems, C.R. Bard Inc., NuVue Therapeutics, Argon Medical Devices, Inc., Becton, Dickinson and Company, Devicor Medical Products Inc. Hologic Inc. Argon Medical Devices, Cook Medical Incorporated, Encapsule Medical Devices LLC., Johnson & Johnson, Galini SRL, Intact Medical Corporation, Conceptus INC, Hologic Inc., Karl Storz GmbH & Co. Kg, and GE Healthcare.

LIST OF TABLES

Table 1 Breast Biopsy Market Industry Synopsis, 2018–2023

Table 2 Global Breast Biopsy Market Estimates & Forecast, 2018–2023, (USD Million)

Table 3 Global Breast Biopsy Market, by Region, 2018–2023, (USD Million)

Table 4 Global Breast Biopsy Market, by Diagnosis, 2018–2023, (USD Million)

Table 5 Global Breast Biopsy Market, by Treatment, 2018–2023, (USD Million)

Table 6 Global Breast Biopsy Market, by End-User, 2018–2023, (USD Million)

Table 7 North America: Breast Biopsy Market, by Diagnosis, 2018–2023, (USD Million)

Table 8 North America: Breast Biopsy Market, by Treatment, 2018–2023, (USD Million)

Table 9 North America: Breast Biopsy Market, by End-User, 2018–2023, (USD Million)

Table 10 US: Breast Biopsy Market, by Diagnosis, 2018–2023, (USD Million)

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/breast-biopsy-market-6288